Management of children and adults with all stages of nodular lymphocyte predominant Hodgkin lymphoma — All <scp>St<i>AGE</i>s</scp>: A consensus‐based position paper from the Hodgkin lymphoma subgroup of the <scp>UK</scp> National Cancer Research Institute
Ananth Shankar, Georgina Hall, Pam McKay, Eve Gallop‐Evans, Patrick Fielding, Graham P. Collins
Abstract
A consensus statement for the management for patients of all ages with all stages of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) - All StAGEs - is proposed by representatives of the UK National Cancer Research Institute (NCRI) Hodgkin lymphoma study group and the Children's Cancer & Leukaemia Group. Based on current practices and published evidence, a consensus has been reached regarding diagnosis, staging and risk-ik7 stratified management which includes active surveillance, low- and standard-dose immunochemotherapy and radiotherapy.
Topics & Concepts
LymphomaHodgkin lymphomaMedicineRadiation therapyPosition statementInternal medicineOncologyConsensus conferenceHodgkin's lymphomaFamily medicineLymphoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia researchLung Cancer Treatments and Mutations